Cell Therapy Market Growth, Demand and Challenges of the Key Industry Players  2024-2032
                     Global Cell Therapy 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
IMARC Group is  a g lobal  management  consul t ing f i rm that  he lps the wor ld ’s  most  ambi t ious 
changemakers  to create a las t ing impact .  Across the s ix  major  cont inents  and 100+ count r ies ,  we 
work a longside our  bus iness par tners  as one team wi th  a common ambi t ion to achieve unparal le led 
resul ts ,  gain a compet i t ive edge,  and t ransform indust r ies .  IMARC Group excels  in  unders tanding 
i ts  c l ients ’  bus iness pr ior i t ies  and del iver ing ta i lored solut ions that  dr ive meaningfu l  outcomes.  Our 
c l ient  base spans over  3,000 organizat ions in  the pr ivate,  publ ic ,  and soc ia l  sectors ,  ranging f rom 
high-growth s tar tups to For tune 500 companies.
We prov ide a comprehensive sui te of  market  entry  and expansion serv ices.  Our of fer ings inc lude 
thorough market  assessment ,  feas ib i l i ty  s tudies,  company incorporat ion ass is tance,  fac tory  setup 
suppor t ,  regulatory  approvals and l icens ing navigat ion,  branding,  market ing and sales st rategies,  
compet i t ive landscape and benchmark ing analyses,  pr ic ing and cost  research,  and procurement  
research.  These serv ices are des igned to ass is t  companies in  evaluat ing market  oppor tuni t ies ,  
set t ing up new ent i t ies ,  navigat ing regulatory landscapes,  boost ing brand v is ib i l i ty ,  analyz ing 
compet i tors,  and opt imiz ing procurement  s t rategies.
A cc o r d i ng  t o  t h e  l a t e s t  r e p o r t  b y  I M A R C  G ro u p ,  t i t l e d  " C e l l  T h e r a p y  M ar k e t :  G l o b a l  
I n d u s t r y  T re n d s ,  S h a re ,  S i z e ,  Gr o w th ,  O p p o r t u n i ty  an d  F o r e ca s t  2 0 2 4 -
20 3 2 , "  t h e  g l o b a l  c e l l  t h e r a p y  ma r k e t  s i z e  r e a c h ed  U S $  1 3 . 5  B i l l i o n  i n  20 2 3 .
C e l l  t h e r ap y ,  a l s o  k no w n  a s  c ry o t h e ra p y ,  i s  a  c u t t i n g - e d g e  me d i c a l  t r e a tm e n t  t h a t  
Report ha r n e s se s  t he  p o w e r  o f  l i v i n g  c e l l s  t o  t r e a t  v a r i o us  d i s ea s e s  a n d  c o nd i t i o n s .  I t  r e l i e s  on  t h e  u n i q ue  a b i l i t i e s  o f  c e l l s  t o  r e p a i r ,  r e p l a ce ,  o r  r e ge n e r a te  d a ma g e d  o r  
dy s f u n c t i o n a l  t i s su e s  w i t h i n  t he  b o d y .  I t  i s  w i d e l y  us e d  f o r  v a r i o us  m e d i ca l  
Highlight and ap p l i c a t i o ns ,  s u c h  as  c a n c e r  t r e a tm e n t  a n d  r e g en e r a t i ve  m ed i c i n e .  I t  i n v o l v e s  t he  i s o l a t i o n ,  m a n i p u l a t i o n ,  a n d  t r a n s p l a n t a t i o n  o f  c e l l s  t o  r e s t o r e  o r  e n h a nc e  th e  n a t u ra l  
he a l i n g  p ro c e s se s  o f  t h e  bo d y .  
Description I t  c a n  b e  cu s t o m i z e d  t o  t a r g e t  s p e c i f i c  t i s su e s  o r  d i s ea s e s .  I t  i s  w i de l y  u se d  i n  c a n ce r  
t r e a t me n t  t o  r e c og n i z e  a n d  a t t a c k  c a n ce r  c e l l s  w h i l e  s pa r i n g  h e a l t h y  o n e s  a nd  r e d u c i n g  
co l l a t e r a l  d a ma g e .  B e s i d es  t h i s ,  a s  i t  o f t e n  r e su l t s  i n  f ew e r  s i d e  e f f e c t s  c o mp a r ed  t o  
ma n y  co n v e n t i o n a l  t r e a t m en t s ,  t h e  de m a n d  f o r  ce l l  t h e ra p y  i s  r i s i n g  ac r o s s  t h e  g l o b e .
R eq u e s t  f o r  a  P D F  sa m p le  o f  th i s  r ep o r t :  
h t t p s : / /w w w . i ma r c g r o u p . co m / ce l l - t h e r ap y - ma r k e t / r e q u e s t s a mp l e
Report Description
Global  Cel l  Therapy Market  Trends:
The increas ing preva lence of  chron ic  d iseases,  such as cancer ,  card iovascular  d isorders,  and auto immune 
condi t ions,  represents  one of  the  pr imary fac tors  dr iv ing the market .  Apar t  f rom th is ,  rap id  advancements  
in  s tem ce l l  research,  genet ic  engineer ing,  and ce l l  cu l tur ing techniques are enabl ing the  development  o f  
increasing ly  sophist icated and ef fec t ive ce l l -based therap ies .  
Fur thermore,  regula tory  agenc ies wor ldwide are under tak ing severa l  s teps to  s t reaml ine the approval  
process for  ce l l  therap ies ,  which is  s t rengthening  the growth of  the market .  Th is  regula tory suppor t  is  
acce lerat ing the development  and commerc ia l izat ion of  ce l l  therap ies ,  reduc ing the t ime and costs  invo lved 
in  br ing ing these t reatments  to  market .
Looking forward,  the market  value is  projected to reach US$ 50.5 Bi l l ion by 2032,  expanding at  a  
CAGR of  15.28% during 2024-2032.
View Report  TOC,  F igures and Tables :  ht tps: / /www.imarcgroup.com/cel l - therapy-market
Breakup by Cell Type:
• Stem Cel l
o Bone Marrow
o Blood
o Umbil ical  Cord-Derived
o Adipose-Derived Stem Cel l
o Others
Report • Non-stem Cel l
 
Segmentation
Breakup by  Therapy Type:
• Autologous
• Allogeneic
Breakup by Therapeutic Area:
• Malignancies
• Musculoskeletal  Disorders
• Autoimmune Disorders
• Dermatology
• Others
Breakup by End User:
Report • Hospitals and Cl inics
• Academic and Research Insti tutes
Segmentation
Breakup by Region:
• North America
• Asia-Pacifi c
• Europe
• Latin America
• Middle East and Afr ica
• AlloSource
• Anterogen Co. Ltd.
• Cel ls  for Cel ls
• Holostem Terapie Avanzate S.r. l .
Competitive 
• JCR Pharmaceuticals
Landscape • Kolon TissueGene Inc
with Key • MEDIPOST
• Mesoblast Limited
Players
• NuVasive
• Stemedica Cel l  Technologies Inc.
• Stempeutics Research Pvt.  Ltd
• Vericel Corporation
What was the size of the global cell therapy market in 
2023?
What is the expected growth rate of the global cell 
therapy market during 2024-2032?
What has been the impact of COVID-19 on the global 
cell therapy market?
Key 
What are the key factors driving the global cell therapy 
Questions market?
Answered in What is the breakup of the global cell therapy market based on the cell type?
the Report What is the breakup of the global cell therapy market 
based on the therapy type?
What is the breakup of the global cell therapy market 
based on the therapeutic area?
What are the key regions in the global cell therapy 
market?
Who are the key players/companies in the global cell 
therapy market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  C e l l  T h e r a p y  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  C e l l  T y p e
    6 . 1     S t e m  C e l l
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  K e y  S e g m e n t s
           6 . 1 . 2 . 1  B o n e  M a r r o w
           6 . 1 . 2 . 2  B l o o d
           6 . 1 . 2 . 3  U m b i l i c a l  C o r d - D e r i v e d
           6 . 1 . 2 . 4  A d i p o s e - D e r i v e d  S t e m  C e l l
           6 . 1 . 2 . 5  O t h e r s
        6 . 1 . 3  M a r k e t  F o r e c a s t
       
    6 . 2     N o n - s t e m  C e l l
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  T h e r a p y  T y p e
    7 . 1     A u t o l o g o u s
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
    7 . 2     A l l o g e n e i c
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
8    M a r k e t  B r e a k u p  b y  T h e r a p e u t i c  A r e a
    8 . 1     M a l i g n a n c i e s
Table of         8 . 1 . 1  M a r k e t  T r e n d s
        8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     M u s c u l o s k e l e t a l  D i s o r d e r s
Contents         8 . 2 . 1  M a r k e t  T r e n d s        8 . 2 . 2  M a r k e t  F o r e c a s t
    8 . 3     A u t o i m m u n e  D i s o r d e r s
        8 . 3 . 1  M a r k e t  T r e n d s
        8 . 3 . 2  M a r k e t  F o r e c a s t
    8 . 4     D e r m a t o l o g y
        8 . 4 . 1  M a r k e t  T r e n d s
        8 . 4 . 2  M a r k e t  F o r e c a s t
    8 . 5     O t h e r s
        8 . 5 . 1  M a r k e t  T r e n d s
        8 . 5 . 2  M a r k e t  F o r e c a s t
9    M a r k e t  B r e a k u p  b y  E n d  U s e r
    9 . 1     H o s p i t a l s  a n d  C l i n i c s
        9 . 1 . 1  M a r k e t  T r e n d s
        9 . 1 . 2  M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
h t t p s : / / w w w. im a rcg ro u p . co m / c e l l - t h e r a p y - m a r ke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: